ReviewCancers2025

Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data.

Pierluigi Puca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.